Organon Pharma Indonesia Tbk. vs Mega Perintis Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Mega Perintis Tbk. trades at Rp710 (market cap 617.82B, 81.3K 24h volume). The key difference: Mega Perintis Tbk. is far larger — about 5.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | ZONE | |
|---|---|---|
Market Cap | 104.4B | 617.82B |
Volume | — | 81.3K |
Lot | — | 813 |
Turnover | — | 57.11M |
Average Price | — | 702.45 |
Value | — | 57.11M |
Indicative Equilibrium Price | — | 710 |
Indicative Equilibrium Volume | — | 4 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Mega Perintis Tbk (Company) was established based on the notarial deed No. 3, dated October 21, 2005, of Ruli Iskandar, S.H. The Company, Manzone and Menstop brand owners
Read more on ZONE →